(Q33440579)

26 July 2017

title

Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial (English)

1 reference

Duchenne muscular dystrophy

26 July 2017

0 references

1 reference

5

Frédéric Gottrand

0 references

Régis Hankard

object named as

Régis Hankard

7

0 references

author name string

Elise Mok

1

1 reference

26 July 2017

Guy Letellier

2

1 reference

26 July 2017

Jean-Marie Cuisset

3

1 reference

26 July 2017

André Denjean

4

1 reference

26 July 2017

Corinne Alberti

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

6 May 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

4

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

e5448

1 reference

Creative Commons Attribution 4.0 International

26 July 2017

copyright license

start time

6 May 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Glutamine supplementation in serious illness: a systematic review of the evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Effect of glutamine on leucine metabolism in humans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Two-, six-, and 12-minute walking tests in respiratory disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Total body potassium and water, and exchangeable sodium, in muscular dystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Two minute walking distance in cystic fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Nutritional therapy improves function and complements corticosteroid intervention in mdx mice

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

alpha7B integrin changes in mdx mouse muscles after L-arginine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

L-arginine improves dystrophic phenotype in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0005448

Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Systemic administration of L-arginine benefits mdx skeletal muscle function

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

High protein diet has beneficial effects in murine muscular dystrophy.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673684

Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species

31 October 2018

1 reference

12 December 2020

The significance of decreased body potassium concentrations in patients with muscular dystrophy and nondystrophic relatives

1 reference

12 December 2020

Intracellular free amino acid concentration in human muscle tissue

1 reference

12 December 2020

The assessment of muscle mass in progressive neuromuscular disease

1 reference

12 December 2020

Muscle wasting in muscular dystrophy: Decreased protein synthesis or increased degradation?

1 reference

12 December 2020

Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine

1 reference

12 December 2020

Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy

1 reference

12 December 2020

Glutamine metabolism in children with short-bowel syndrome: a stable isotope study

1 reference

12 December 2020

Response of glutamine metabolism to exogenous glutamine in humans

1 reference

12 December 2020

Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy

1 reference

12 December 2020

Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy?

1 reference

12 December 2020

Pre-clinical screening of drugs using the mdx mouse

1 reference

12 December 2020

Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy

1 reference

12 December 2020

Comparison of oxygen consumption measurements in children with cerebral palsy to children with muscular dystrophy

1 reference

12 December 2020

Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients

1 reference

12 December 2020

Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement

1 reference

12 December 2020

Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0005448

Identifiers

DOI

1 reference

26 July 2017

0 references

1 reference

26 July 2017

1 reference